Alkermes plc - Ordinary Shares (ALKS) Social Stream



Alkermes plc - Ordinary Shares (ALKS): $30.00

0.52 (+1.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ALKS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

Alkermes plc (ALKS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALKS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 7 $36 $24 $29 $28.06 3.35%
2021-11-15 7 $33 $24 $28.625 $28.06 2.01%
2021-11-16 7 $33 $24 $28.5 $28.06 1.57%
2022-01-23 8 $33 $22 $27.777 $28.06 -1.01%
2022-01-27 8 $33 $22 $28.222 $28.06 0.58%
2022-02-15 7 $33 $22 $28.222 $28.06 0.58%
2022-03-14 8 $33 $22 $27.666 $28.06 -1.4%

The Trend in the Analyst Price Target


ALKS's average price target has moved up $5.45 over the prior 43 weeks.

ALKS reports an average of 1.95% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 10 29 16 22.440 23.08 -2.77%
2021-06-26 10 29 16 22.440 24.13 -7%
2021-07-17 10 29 16 22.630 23.71 -4.56%
2021-08-01 10 33 16 25.000 25.87 -3.36%
2022-01-27 8 33 22 28.222 24.56 14.91%

ALKS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.63 2 0 5 0 0 8

The Trend in the Broker Recommendations


Over the past 59 days, ALKS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Alkermes plc's upside potential (average analyst target price relative to current price) is greater than 111.89% of them.
  • ALKS has a higher average analyst price target than 98.01% of stocks in the large market cap category.
  • In the context of stocks in the large market cap category, Alkermes plc's number of analysts covering the stock is higher than 129.22% of them.
  • Alkermes plc's variance in analysts' estimates is lower than -113.61% of Pharmaceutical Products stocks.

Stocks similar to Alkermes plc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ABCL, VIR, and VCEL.

What is the outlook for ALKS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5964 seconds.